We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.7B
AUM Growth
-$333M
Cap. Flow
-$906M
Cap. Flow %
-1.66%
Top 10 Hldgs %
14.84%
Holding
1,599
New
74
Increased
554
Reduced
585
Closed
78

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$114M
2
ORCL icon
Oracle
ORCL
+$96.1M
3
ALL icon
Allstate
ALL
+$88.6M
4
QCOM icon
Qualcomm
QCOM
+$88.3M
5
MRSH
Marsh
MRSH
+$73.9M

Sector Composition

Rank Sector Weight
1 Healthcare 17.55%
2 Financials 15.04%
3 Technology 12.33%
4 Energy 9.55%
5 Industrials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJI
301
DELISTED
South Jersey Industries, Inc.
SJI
$33.3M 0.06%
974,820
+286,007
+42% +$10.4M
MDCO
302
DELISTED
Medicines Co
MDCO
$33.2M 0.06%
873,182
+268,282
+44% +$11.9M
NI icon
303
NiSource
NI
$22.4B
$33.1M 0.06%
1,306,200
-20,100
-2% -$501K
RSPP
304
DELISTED
RSP Permian, Inc.
RSPP
$33M 0.06%
1,024,123
+131,508
+15% +$4.89M
AIT icon
305
Applied Industrial Technologies
AIT
$12.7B
$33M 0.06%
558,691
+42,769
+8% +$2.62M
ECOL
306
DELISTED
US Ecology, Inc.
ECOL
$32.9M 0.06%
652,225
+155,498
+31% +$7.69M
CX icon
307
Cemex
CX
$17.7B
$32.9M 0.06%
3,495,779
-156,285
-4% -$1.38M
PBR.A icon
308
Petrobras Class A
PBR.A
$109B
$32.9M 0.06%
4,403,795
BKNG icon
309
Booking.com
BKNG
$134B
$32.8M 0.06%
438,800
-108,750
-20% -$7.97M
CNMD icon
310
CONMED
CNMD
$1.24B
$32.7M 0.06%
642,879
-31,777
-5% -$1.57M
TEVA icon
311
Teva Pharmaceuticals
TEVA
$36.3B
$32.5M 0.06%
978,883
+43,757
+5% +$1.35M
TTEK icon
312
Tetra Tech
TTEK
$7.93B
$32.4M 0.06%
3,536,095
-2,332,385
-40% -$20.8M
MBUU icon
313
Malibu Boats
MBUU
$535M
$32.3M 0.06%
1,250,081
-23,836
-2% -$562K
RRX icon
314
Regal Rexnord
RRX
$14.2B
$32.2M 0.06%
395,277
+8,259
+2% +$653K
CORE
315
DELISTED
Core Mark Holding Co., Inc.
CORE
$32.1M 0.06%
970,329
+69,048
+8% +$2.35M
LLY icon
316
Eli Lilly
LLY
$1.06T
$32M 0.06%
388,680
-76,207
-16% -$6.22M
EXAS
317
DELISTED
Exact Sciences
EXAS
$31.9M 0.06%
901,049
+335,155
+59% +$10.3M
CHRD icon
318
Chord Energy
CHRD
$7.82B
$31.7M 0.06%
3,937,614
+490,503
+14% +$5.37M
CLVS
319
DELISTED
Clovis Oncology, Inc.
CLVS
$31.6M 0.06%
+337,669
New +$20.7M
HOPE icon
320
Hope Bancorp
HOPE
$1.72B
$31.5M 0.06%
1,690,069
+159,340
+10% +$2.96M
CHCO icon
321
City Holding Co
CHCO
$1.94B
$31.4M 0.06%
477,023
-36,241
-7% -$2.4M
AVGO icon
322
Broadcom
AVGO
$1.87T
$31.4M 0.06%
1,347,890
-187,640
-12% -$4.35M
PAYC icon
323
Paycom
PAYC
$6.47B
$31.3M 0.06%
457,506
-95,687
-17% -$6.15M
STT icon
324
State Street
STT
$50.6B
$31.2M 0.06%
348,151
-18,303
-5% -$1.52M
SAIA icon
325
Saia
SAIA
$11.3B
$31.2M 0.06%
607,947
-495
-0.1% -$22.9K

Similar funds

Macquarie Group's Q2 2017 Portfolio in Review

As of Q2 2017, Macquarie Group held 1,599 positions worth $54.7B, down 0.61% from $55B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2017 filing shows 74 new, 554 increased, 585 reduced and 78 closed positions. Its largest new stake was Altaba Inc: 830,118 shares worth $45.2M. The largest sale was Quest Diagnostics, an estimated $114M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q2 2017 buy was Altaba Inc: 830,118 shares worth $45.2M.
  • Macquarie Group added most to Marathon Oil Corporation in Q2 2017, an estimated $399M increase.
  • Macquarie Group's biggest Q2 2017 reduction was Quest Diagnostics, cutting an estimated $114M.
  • Macquarie Group fully exited Syngenta Ag in Q2 2017, selling an estimated $69.7M.
  • Macquarie Group's ten largest holdings make up 15% of its $54.7B portfolio in Q2 2017.
  • Macquarie Group opened 74 new positions and closed 78 in Q2 2017.
  • Macquarie Group's portfolio value fell 0.61% quarter-over-quarter to $54.7B.

Based on Macquarie Group's 13F filing for Q2 2017, filed 14 Aug 2017.